Poecilia formosa (Amazon molly)
| UniProt ID | Protein Name | Gene Symbol | No. of Glycosylation Sites | No. of GlyTouCan IDs | Disease Ontology |
|---|---|---|---|---|---|
| A0A087YG09 | Hyaluronidase |
|
1 | 0 |
|
| A0A096M5H0 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
| A0A087YRE2 | Rhodopsin |
|
2 | 0 |
|
| A0A087XWT0 | Protein adenylyltransferase FICD |
|
1 | 0 |
|
| A0A096LXG7 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
| A0A087XBT5 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
| A0A087Y9H4 | Voltage-dependent T-type calcium channel subunit alpha |
|
1 | 0 |
|
| A0A087X6W4 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
| G4XJR0 | Rhodopsin |
|
2 | 0 |
|
| A0A096M3B4 | Angiotensin-converting enzyme |
|
2 | 0 |
|
| A0A096MGR8 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
| A0A087YBC0 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
| A0A096LRN2 | Hyaluronidase |
|
1 | 0 |
|
| A0A087XVG9 | P2X purinoceptor |
|
1 | 0 |
|
| A0A096M1C5 | Beta-secretase 2 |
|
2 | 0 |
|
| A0A087XU11 | P2X purinoceptor |
|
1 | 0 |
|
| A0A087XBN1 | Phosphoinositide phospholipase C |
|
1 | 0 |
|
| A0A087YDL6 | Angiotensin-converting enzyme |
|
2 | 0 |
|
| A0A087X800 | P2X purinoceptor |
|
1 | 0 |
|
| A0A087YI18 | Voltage-dependent N-type calcium channel subunit alpha |
|
1 | 0 |
|
| A0A087YBW8 | Hyaluronidase |
|
1 | 0 |
|
| A0A087YMN4 | Fibroblast growth factor receptor |
|
8 | 0 |
|
| A0A087XR77 | Voltage-dependent P/Q-type calcium channel subunit alpha-1A |
|
1 | 0 |
|
| A0A087X2U7 | Hyaluronidase |
|
1 | 0 |
|
| A0A087Y874 | Rhodopsin |
|
2 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025